Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
The Faces of Luminex: Christine Valle, Global Marketing
Here at Luminex, each system we develop has a dedicated team managing every detail of the instruments, reagents, specifications, and more. For our xMAP® Technology, that team is led by Christine Valle, Director of Global Systems & Consumables Marketing. The proud Texas native came to Luminex in 2011 and holds a bachelor’s degree from Sam Houston State University.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
March 5
Luminex Corporation to Present at the Barclays Global Healthcare Conference
February 8
Luminex Corporation Declares First Quarter Cash Dividend
February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results
January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio
November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results
Drug Discovery Summit
11-12 June
Berlin, Germany
UKEV Summer School 2019
16-19 July
Nottingham, UK
SSM
3-4 September
Zurich, Switzerland
